Prescription drug companys’ exclusive marketing to children in excess of $4 billion for popular prescription medications like Paxil, Prozac, Zoloft, Luvox, Celexa and Effexor have come under fire by government regulators in recent months.
According to recently published FDA warnings and reports many drugs currently being marketed to children have not only NOT been clinically proven to help children with anxiety, depression and related disorders, the drugs may actually increase the prevalence of these diseases and may lead to a higher risk of suicidal thoughts in children and teens.
Two months after a slew of warnings from the FDA, one drug manufacturer, according to published reports, told their sales representative to stay mum regarding the warnings.
With the first warnings alerting parents in early summer 2004, the FDA has followed up with even more clinical data, recently released by the Drug manufacturers.
Congress has begun pressuring the FDA in recent weeks to immediately begin proceedings to determine why further action was not taken after the FDA learned of suicidal reports in the late 1990’s.
The Food and Drug Administration will examine clinical trial data for thousands of depressed adults to see if they, like children, suffered increased suicidal thoughts and behaviors while taking antidepressants. Dr. Janet Woodcock, acting FDA deputy commissioner, could not say how long the exhaustive analysis would take or how much it would cost.